Finanzas de CorVel Corp (CRVL)CRVLCorVel Corp

CorVel Corporation (CRVL) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Patient management Services, accounting for 61.6% of total sales, equivalent to $153.08M. Another important revenue stream is Network Solution Services. Understanding this composition is critical for investors evaluating how CRVL navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, CorVel Corporation maintains a gross margin of 26.08%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 16.67%, while the net margin is 12.40%. These profitability ratios, combined with a Return on Equity (ROE) of 30.70%, provide a clear picture of how effectively CRVL converts its operational activities into shareholder value.

In the context of the broader market, CRVL competes directly with industry leaders such as BWIN and NP. With a market capitalization of $4.03B, it holds a significant position in the sector. When comparing efficiency, CRVL's gross margin of 26.08% stands against BWIN's N/A and NP's N/A. Such benchmarking helps identify whether CorVel Corporation is trading at a premium or discount relative to its financial performance.

CorVel has demonstrated robust financial growth with Q1 2027 net profit reaching $32.22 million, up from $27.23 million year-over-year, and earnings per share increasing to $0.63 from $0.52. Revenue also rose by 10.7% year-over-year to $259.92 million, reflecting strong business expansion.